Home/Rona Therapeutics/Alex M. DePaoli, M.D.
AM

Alex M. DePaoli, M.D.

Chief Medical Officer and Executive Vice President of Translational Research

Rona Therapeutics

Rona Therapeutics Pipeline

DrugIndicationPhase
RN0191Cardiovascular Disease (PCSK9)Phase 1
RN0361Hypertriglyceridemia (ApoC3)Phase 1
RN3161Obesity (INHBE)IND-Enabling
RN5681ASCVD (PCSK9-Lp(a))Preclinical
RN1871Hypertension (AGT)Phase 1